Xeris Pharmaceuticals | Resultado Líquido



Net Income Alterar Data
Adcock Ingram Holdings ZAR 369.84M 74.33M 2024-06
Celltrion KRW 85.59B 7.58B 2024-09
Cspc Pharmaceutical CNY 757.66M 649.86M 2024-09
Dianthus Therapeutics USD -28440000 3.27M 2024-12
Ecofibre AUD 617K 46.2M 2024-06
Eli Lilly USD 4.41B 3.44B 2024-12
Kangmei Pharma CNY -10744790 19.03M 2024-09
Knight Therapeutics CAD 85K 2.03M 2024-09
Laboratorios Farma EUR 92.54M 63.16M 2024-12
Malin Corporation EUR 0 1.1M 2024-06
Medical Developments International AUD -15020000 4.08M 2024-06
Neuren Pharmaceuticals AUD 134.03M 126.01M 2024-12
Organigram Holdings CAD -22957000 17.52M 2024-12
Pacira USD 16.04M 159.51M 2024-12
Perrigo USD -44500000 23.5M 2024-12
Pharma Mar EUR 18.68M 14.78M 2024-12
Qiagen NV USD 88.32M 9.74M 2024-12
Sartorius EUR 14.2M 9.7M 2024-09
Sino Biopharmaceutical CNY 482.67M 1.03B 2024-12
Supernus Pharmaceuticals USD 15.33M 23.17M 2024-12
Tilray USD -85342000 46.18M 2024-11
Zz Pientze Pharmaceu 965.15M 218.11M 2024-09



Xeris Pharmaceuticals Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.